NCT03677986View on ClinicalTrials.gov

Buprenorphine Treatment Engagement and Overdose Prevention

NACompletedINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

May 1, 2019

Primary Completion Date

July 28, 2020

Study Completion Date

October 20, 2020

Conditions
Opioid-use Disorder
Interventions
BEHAVIORAL

Video DOT+

Participants will receive financial incentives for recording and submitting videos of themselves taking their daily buprenorphine dose.

Trial Locations (1)

21224

Center for Learning and Health, Baltimore

All Listed Sponsors
collaborator

Centers for Disease Control and Prevention

FED

lead

Johns Hopkins University

OTHER

NCT03677986 - Buprenorphine Treatment Engagement and Overdose Prevention | Biotech Hunter | Biotech Hunter